Posters
(results will display both Free Papers & Poster)
Intra and early postoperative complications in phacoemulsification cataract surgery: a retrospective chart review of 5186 cases
Poster Details
First Author: I.Tzamichas GREECE
Co Author(s): E. Karasavvidou C. Keskini A. Papazacharia C. Kampos D. Balatsoukas
Abstract Details
Purpose:
To present the frequency of intraoperative and early postoperative complications related to phacoemulsification cataract extraction that were recorded at Hippokrateio General Hospital of Thessaloniki during a 3-year period.
Setting:
Department of Ophthalmology, Hippokrateio General Hospital of Thessaloniki, Thessaloniki, Greece
Methods:
A retrospective chart review of 5186 cases that underwent cataract surgery by phacoemulsification in the last three years at Hippokrateio General Hospital of Thessaloniki was performed. Details of intraoperative (posterior capsular rupture, vitreous loss, dropped nucleus/lens matter, zonular detachment) and early postoperative complications (IOL dislocation, ocular hypertension, TASS, endophthalmitis) were recorded.
Results:
5186 cataract surgeries were performed.22% of all eyes were considered high-risk due to brunescent/intumescent cataract, pseudoexfoliation, small pupil and/or IFIS. Posterior capsular rupture(3,8%), vitreous loss due to posterior capsular rupture or zonular detachment(2,6%) and dropped nucleus/lens matter(0,35%) occurred intraoperatively. Postoperatively, IOL dislocation(0,7%), luxation of IOL into the posterior segment(0,15%) and endophthalmitis(0,04%) were observed. Those complications were successfully treated with either anterior or 23g pars plana vitrectomy followed by sulcus IOL placement,while transscleral or sutureless intrascleral IOL fixation was performed in insufficient zonular/capsular support. TASS was noted in 0,2% and short-term ocular hypertension in 0,9% of patients, both effectively treated conservatively
Conclusions:
The rate of intra- and early postoperative complications, which were successfully treated in our department, agrees with internationally reported data despite the significant number of high-risk cases.
Financial Disclosure:
None